Vemurafenib and TIL Therapy for Metastatic Melanoma
Clinical trial NCT02354690 · COMPLETED
Trial details
- NCT number
- NCT02354690
- Sponsor
- Inge Marie Svane
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2018-12-31
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.